Pamela Ann Connealy
Director · Orchestra BioMed Holdings, Inc.
- 2024
- Jun 25, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pamela Ann Connealy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Darren Sherman - $364K in OBIO purchases and sales in the last 12 months
- David P. Hochman - $149K in OBIO purchases and sales in the last 12 months
- Jakob Dupont - $107K in PYXS purchases and sales in the last 12 months
- Eric S. Fain - $83K in OBIO purchases and sales in the last 12 months
- Jason Aryeh - $37K in OBIO purchases and sales in the last 12 months
- RTW INVESTMENTS, LP - $132 in OBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pamela Ann Connealy?
Pamela Ann Connealy is a corporate insider, tracked as Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pamela Ann Connealy last file a Form 4?
The most recent primary Form 4 on record is dated 25 June 2026, one of 4 filings going back to 2024.
Has Pamela Ann Connealy been buying or selling stock?
Recorded transactions: 2 open-market purchases ($174K) and 0 open-market sales across all tracked filings.
